A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy
Bibliographic Data
| ID | 13914280 |
|---|---|
| Authors | Vivian W L Tsang (0000-0001-9401-008X, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada, corresponding author), Dragos C Ragazan (0000-0002-8953-3991, University of British Columbia), Pamela Kryskow (0000-0003-0310-0368, Health and Human Services, Vancouver Island University, Nanaimo, BC, Canada), Zach Walsh (University of British Columbia), Shannon Dames (0000-0003-1609-4243, Health and Human Services, Vancouver Island University, Nanaimo, BC, Canada) |
| Year | 2023 |
| Volume | 56 |
| Issue | 5 |
| Pages | 627-636 |
| Publication date | 2023-09-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Psychoactive Drugs (JOURNAL) |
| Journal identifiers | ISSN: 0279-1072 • E-ISSN: 2159-9777 |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/02791072.2023.2253798 |
| PMID | 37655532 |
| OpenAlex | W4386346817 |
| Language | EN |
| Citations received | 4 |
| References cited | 61 |
The prevalence of depression, anxiety, and post-traumatic stress disorder (PTSD) has increased among healthcare providers, while the effectiveness of conventional treatments remains limited. Ketamine-assisted therapy offers a promising alternative; however, few have integrated ketamine with a group-based therapeutic modality. We report a retrospective, secondary analysis of a 12-week pilot of a Community of Practice (CoP) oriented group therapy program with optional, adjunct ketamine for depression, anxiety, and PTSD in a sample of 57 healthcare providers. All participants moved through the treatment as one group, with 38 electing to also receive three adjunct ketamine sessions in addition to the weekly CoP. Symptoms were assessed at baseline and pilot completion with the PHQ-9 for depression, GAD-7 for anxiety, and PCL-5 for PTSD. We observed significant reductions in the mean change among all participants, suggesting that benefit was derived from the CoP component, with or without ketamine as an adjunct. PHQ-9 scores decreased by 6.79 (95% CI: 5.09-8.49, p p p < .001). Reductions were larger, but statistically nonsignificant, among those receiving ketamine. Further research is required to assess the impact of ketamine as an adjunct in group-based therapies
Adjunct · Anxiety · Depression (economics · Ketamine · Physical therapy · Psychiatry · Medicine · Mental Health Treatment and Access · Treatment of Major Depression · Tryptophan and brain disorders
Improving access to psilocybin-assisted therapy
A Importância Da Psicoterapia, Associada a Utilização Dos Farmacológicos Como Preditores Da Qualidade De Vida De Pacientes Sob a Exposição De Eventos Traumáticos
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
A clinical protocol for group-based ketamine-assisted therapy in a community of practice
Predicting Responses to Psychedelics
Screening for anxiety disorders with the GAD-7 and GAD-2
The Psychological Impact of Epidemic and Pandemic Outbreaks on Healthcare Workers
Why Psychologists Should by Default Use Welch’s t-test Instead of Student’s t-test
Experiences of frontline healthcare workers and their views about support during Covid-19 and previous pandemics
Evidence Relating Health Care Provider Burnout and Quality of Care
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder
Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7)
Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the Covid-19 pandemic
The Posttraumatic Stress Disorder Checklist for DSM‐5 (PCL‐5)
A Brief Measure for Assessing Generalized Anxiety Disorder
The PHQ-9
Motives for the use of serotonergic psychedelics
“My problems aren't severe enough to seek help”
A Cohort-Based Case Report
How to Reduce Mental Health Burden in Health Care Workers During Covid-19?–A Scoping Review of Guideline Recommendations
Relational Group Psychotherapy
Psychedelic-Assisted Group Therapy
Ketamine Assisted Psychotherapy (KAP)
Health, stress and coping
| Unique citing works | 4 |
|---|---|
| Citations per year | 2 |
| Citation span | 2024 - 2026 (3) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 4 |